1. Chlorpromazine versus lithium for people with schizophrenia
- Author
-
Shareen Rikhraj, Daniel Linhares Cardoso, Katie Tyrrell, and Claudia Mancias Guerra
- Subjects
Medicine General & Introductory Medical Sciences ,medicine.medical_specialty ,Lithium (medication) ,business.industry ,Schizophrenia (object-oriented programming) ,030227 psychiatry ,03 medical and health sciences ,0302 clinical medicine ,mental disorders ,medicine ,Pharmacology (medical) ,Chlorpromazine ,business ,Psychiatry ,030217 neurology & neurosurgery ,medicine.drug - Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To investigate the effects of chlorpromazine alone versus lithium alone in the treatment of schizophrenia, schizophrenia‐like psychoses and schizoaffective psychoses. It is expected that the implementation of several subgroup analyses may be possible (see Subgroup analysis and investigation of heterogeneity).
- Published
- 2017